Assessment of the evolution of anxiety during a treatment of major depressive disorders in ambulatory patients in general practice with fluoxetine (Prozac) 20 mg

Author： Mesters P.   Martens S.   Taymans J.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 290-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Onset of action of fluoxetine 20 mg (Prozac) among ambulatory patients suffering from depressive disorders

By Mesters P.   Sangeleer M.   Bussios G.   Bourgeois M.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 291-291

Elsevier

Access to resources Recommend Favorite

Olanzapine/Fluoxetine: A Review of its Use in Patients With Treatment-Resistant Major Depressive Disorder

By Croxtall Jamie D.   Scott Lesley J.  

CNS Drugs, Vol. 24, Iss. 3, 2010-03 ,pp. : 245-262

Adis International

Access to resources Recommend Favorite

Quetiapine: novel uses in the treatment of depressive and anxiety disorders

By Ravindran Arun V   Al-Subaie Abdullah   Abraham Gebrehiwot  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 10, 2010-10 ,pp. : 1187-1204

Informa Healthcare

Access to resources Recommend Favorite

Escitalopram: A Review of its Use in the Management of Major Depressive and Anxiety Disorders

By Waugh J.   Goa K.L.  

CNS Drugs, Vol. 17, Iss. 5, 2003-01 ,pp. : 343-362

Adis International

Access to resources Recommend Favorite

Escitalopram: In the Treatment of Major Depressive Disorder in Adolescent Patients

By Yang Lily P.H.   Scott Lesley J.  

Pediatric Drugs, Vol. 12, Iss. 3, 2010-06 ,pp. : 155-163

Adis International

Access to resources Recommend Favorite